Detection of hepatitis B virus cccDNA in peripheral blood monuclear cells and liver tissues in hepatitis B virus-related disease patients after liver transplantation

Zhang Rong,Wu Zhong-jun,Cao Chen,Chen Ying
DOI: https://doi.org/10.3969/j.issn.1673-8225.2011.05.006
2011-01-01
Abstract:BACKGROUND:Life-long prophylaxis against hepatitis B virus (HBV) recurrence is recommended in patients transplanted for HBV-related disease. But exact mechanism of HBV recurrence and its copy law is unknown. OBJECTIVE:By detection of HBV cccDNA and HBV DNA in peripheral blood mononuclear cells (PBMCs) and liver tissues and serum from HBV-related end-stage liver disease patients before and after liver transplantation. METHODS:PBMCs were isolated from HBV-related end-stage liver disease patients by lymphocyte separation medium. HBVcccDNA in PBMCs and liver tissue and the serum HBVDNA at three periods of before,after liver transplantation and postoperative recurrence were detected by fluorescent quantitative PCR. RESULTS AND CONCLUSION:Before liver transplantation,cccDNA in PBMCs and liver tissues were positive in 12 cases and 6 cases,the detection rates were 32.43% and 16.22%,cccDNA copies in PBMCs ranged from 3.028 to 6.508×104 copies/mL,as in liver tissues the range was from 4.158 to 6.234×104 copies/mL. After liver transplantation,cccDNA in PBMCs was positive in one case. In 6 cases of hepatitis B recurrence after liver transplantation,cccDNA in PBMCs was positive in 4 cases,as positive in one case of liver biopsy,and all 6 cases positive for serum HBVDNA. Possible way of hepatitis B recurrence of HBV-related end-stage liver disease patients after liver transplantation may be that residual HBV in peripheral mononuclear cells replicate according to cccDNA as the template,and then migrate to the liver.
What problem does this paper attempt to address?